VanEck Pharmaceutical ETF

Price: $91.93
Change: $0.11 (-0.0%)
Last Updated:


Issuer VanEck
Brand VanEck
Structure ETF
Expense Ratio 0.36%
ETF Home Page Home page
Inception Dec 20, 2011

Analyst Report

This ETF is one of several options for achieving exposure to the pharma industry, a corner of the health care market that is capable of delivering big returns but that also comes with some unique risk factors. Given this investment objective, PPH is probably more useful for those looking to achieve tactical exposure to this specific corner of the market; the appeal to buy-and-holders will be limited since many of the components are included in more broad-based funds.

A couple aspects of PPH are noteworthy. First, though PPH is now structured as a true ETF, it used to be one of the HOLDRS products offered by Merrill Lynch. Some of the concentration that was characteristic of those products remains in PPH; the portfolio is relatively shallow and concentration in the top allocations is significant. Further, PPH includes only U.S. stocks, meaning that some of the biggest players in the pharmaceutical industry are excluded from the underlying portfolio.

PPH is a decent option for pharma exposure, but there are probably some better ETFs out there for tapping into this segment of the market. IHE offers better depth of holdings, while DRGS may be appealing to those looking to achieve truly global exposure.

ETF Database Themes

Asset Class Equity
Asset Class Size Multi-Cap
Asset Class Style Blend
Sector (General) Healthcare
Sector (Specific) Pharmaceutical
Region (General) Developed Markets
Region (Specific) Broad

FactSet Classifications

Segment Equity: Global Pharmaceuticals
Category Sector
Focus Health Care
Niche Pharmaceuticals
Strategy Vanilla
Weighting Scheme Market Cap

Trading Data

Open - Volume -
Day Lo - Day Hi -
  • Open
  • Volume
  • Day Lo
  • Day Hi
  • 52 Week Lo $73.34
  • 52 Week Hi $92.97
  • AUM $610.8 M
  • Shares 6.6 M

Historical Trading Data

  • 1 Month Avg. Volume 133,757
  • 3 Month Avg. Volume 148,551

Alternative ETFs in the ETF Database Health & Biotech Equities Category

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FHLC 0.08% $3.0 B 136,389 6.58%
Largest (AUM) XLV 0.09% $39.5 B 8 M 7.39%
Most Liquid (Volume) XBI 0.35% $7.2 B 10 M 5.07%
Top YTD Performer BBC 0.79% $11.1 M 3,335 13.30%

Top 15 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to its peers.

Holdings Comparison

PPH ETF Database Category Average FactSet Segment Average
Number of Holdings 25 83 25
% of Assets in Top 10 65.72% 44.74% 65.72%
% of Assets in Top 15 86.85% 57.34% 86.85%
% of Assets in Top 50 100.03% 92.41% 100.03%

Size Comparison

PPH ETF Database Category Average FactSet Segment Average
Large (>12.9B) 93.71% 51.38% 93.71%
Mid (>2.7B) 5.72% 26.39% 5.72%
Small (>600M) 0.57% 16.29% 0.57%
Micro (<600M) 0.00% 5.19% 0.00%

PPH Valuation

This section compares the P/E ratio of this ETF to its peers.

P/E Ratio
ETF Database Category Average
P/E Ratio
FactSet Segment Average
P/E Ratio

PPH Dividend

This section compares the dividend yield of this ETF to its peers.

PPH ETF Database Category Average FactSet Segment Average
Dividend $ 0.53 $ 0.22 $ 0.53
Dividend Date 2024-04-01 N/A N/A
Annual Dividend Rate $ 1.57 $ 0.40 $ 1.57
Annual Dividend Yield 1.71% 0.60% 1.71%

PPH Price and Volume Charts

View charts featuring PPH price and volume data.

PPH Fund Flows Charts

View charts featuring ETF fund flow data.

5 Day Net Flows: 9.21 M 1 Month Net Flows: 32.09 M 3 Month Net Flows: 55.64 M 6 Month Net Flows: 118.3 M 1 Year Net Flows: 149.42 M 3 Year Net Flows: 295.21 M 5 Year Net Flows: 298.52 M 10 Year Net Flows: 131.95 M

PPH Price vs Flows AUM Influence Charts

View charts that break down the influence that fund flows and price had on overall assets.